Literature DB >> 27228995

Bidirectional signalling between EphA2 and ephrinA1 increases tubular cell attachment, laminin secretion and modulates erythropoietin expression after renal hypoxic injury.

Stéphane Rodriguez1,2, Stefan Rudloff1, Katrin Franziska Koenig1,3, Swapna Karthik1, David Hoogewijs4,5, Uyen Huynh-Do6.   

Abstract

Acute kidney injury (AKI) is common in hospitalized patients and has a poor prognosis, the severity of AKI being linked to progression to chronic kidney disease. This stresses the need to search for protective mechanisms during the acute phase. We investigated kidney repair after hypoxic injury using a rat model of renal artery branch ligation, which led to an oxygen gradient vertical to the corticomedullary axis. Three distinct zones were observed: tubular necrosis, infarction border zone and preserved normal tissue. EphA2 is a receptor tyrosine kinase with pivotal roles in cell architecture, migration and survival, upon juxtacrine contact with its membrane-bound ligand EphrinA1. Following hypoxia, EphA2 was up-regulated in cortical and medullary tubular cells, while EphrinA1 was up-regulated in interstitial cells adjacent to peritubular capillaries. Moreover, erythropoietin (EPO) messenger RNA (mRNA) was strongly expressed in the border zone of infarcted kidney within the first 6 h. To gain more insight into the biological impact of EphA2 and EphrinA1 up-regulation, we activated the signalling pathways in vitro using recombinant EphrinA1/Fc or EphA2/Fc proteins. Stimulation of EphA2 forward signalling in the proximal tubular cell line HK2 increased cell attachment and laminin secretion at the baso-lateral side. Conversely, activation of reverse signalling through EphrinA1 expressed by Hep3B cells promoted EPO production at both the transcriptional and protein level. Strikingly, in co-culture experiments, juxtacrine contact between EphA2 expressing MDCK and EphrinA1 expressing Hep3B was sufficient to induce a significant up-regulation of EPO mRNA production in the latter cells, even in the absence of hypoxic conditions. The synergistic effects of EphA2 and hypoxia led to a 15-20-fold increase of EPO expression. Collectively, our results suggest an important role of EphA2/EphrinA1 signalling in kidney repair after hypoxic injury through stimulation of (i) tubular cell attachment, (ii) secretion of basal membrane proteins and (iii) EPO production. These findings could thus pave the way to new therapeutic approaches.

Entities:  

Keywords:  Bidirectional; EPO; EphA2; EphrinA1; Kidney repair

Mesh:

Substances:

Year:  2016        PMID: 27228995     DOI: 10.1007/s00424-016-1838-1

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  49 in total

1.  Temporally compartmentalized expression of ephrin-B2 during renal glomerular development.

Authors:  Takamune Takahashi; Keiko Takahashi; Sebastian Gerety; Hai Wang; David J Anderson; Thomas O Daniel
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

2.  Membrane repolarization is delayed in proximal tubules after ischemia-reperfusion: possible role of microtubule-organizing centers.

Authors:  Flavia A Wald; Yolanda Figueroa; Andrea S Oriolo; Pedro J I Salas
Journal:  Am J Physiol Renal Physiol       Date:  2003-04-22

3.  Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury.

Authors:  Glenda C Gobe; Nigel C Bennett; Malcolm West; Paul Colditz; Lindsay Brown; David A Vesey; David W Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-08

4.  Podocyte EphB4 signaling helps recovery from glomerular injury.

Authors:  Monika Wnuk; Ruslan Hlushchuk; Mathilde Janot; Gérald Tuffin; Georg Martiny-Baron; Philipp Holzer; Patricia Imbach-Weese; Valentin Djonov; Uyen Huynh-Do
Journal:  Kidney Int       Date:  2012-03-07       Impact factor: 10.612

5.  EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo.

Authors:  Hongshi Xu; Wei Tian; Jessie N Lindsley; Terry T Oyama; Juan M Capasso; Christopher J Rivard; Herbert T Cohen; Serena M Bagnasco; Sharon Anderson; David M Cohen
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-23

6.  In vitro investigation of renal epithelial injury suggests that primary cilium length is regulated by hypoxia-inducible mechanisms.

Authors:  Elizabeth Verghese; Junli Zhuang; Deshira Saiti; Sharon D Ricardo; James A Deane
Journal:  Cell Biol Int       Date:  2011-09       Impact factor: 3.612

7.  Cellular responses to hypoxia after renal segmental infarction.

Authors:  Christian Rosenberger; Wanja Griethe; Gertrud Gruber; Michael Wiesener; Ulrich Frei; Sebastian Bachmann; Kai-Uwe Eckardt
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

8.  Culture of renal tubular cells from the urine of patients with nephropathic cystinosis.

Authors:  L C Racusen; B A Fivush; H Andersson; W A Gahl
Journal:  J Am Soc Nephrol       Date:  1991-02       Impact factor: 10.121

9.  Autocrine transforming growth factor-{beta}1 activation mediated by integrin {alpha}V{beta}3 regulates transcriptional expression of laminin-332 in Madin-Darby canine kidney epithelial cells.

Authors:  Jose V Moyano; Patricia G Greciano; Mary M Buschmann; Manuel Koch; Karl S Matlin
Journal:  Mol Biol Cell       Date:  2010-09-15       Impact factor: 4.138

10.  The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection.

Authors:  Ming-Chang Hu; Mingjun Shi; Han J Cho; Jianning Zhang; Alevtina Pavlenco; Shuzhen Liu; Sachdev Sidhu; Lily J-S Huang; Orson W Moe
Journal:  Kidney Int       Date:  2013-05-01       Impact factor: 10.612

View more
  2 in total

1.  EphA2 and ephrin-A5 are not a receptor-ligand pair in the ocular lens.

Authors:  Catherine Cheng; Velia M Fowler; Xiaohua Gong
Journal:  Exp Eye Res       Date:  2017-06-23       Impact factor: 3.467

2.  Associations of high altitude polycythemia with polymorphisms in EPHA2 and AGT in Chinese Han and Tibetan populations.

Authors:  Lijun Liu; Yao Zhang; Zhiying Zhang; Yiduo Zhao; Xiaowei Fan; Lifeng Ma; Yuan Zhang; Haijin He; Longli Kang
Journal:  Oncotarget       Date:  2017-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.